.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

ESR1 Mutations in HR+/HER2– Breast Cancer: Optimizing Testing Strategies and Treatment Decisions in the Era of Targeted Therapy

EP. 1: ESR1 Mutations in HR+/HER2– Breast Cancer: Optimizing Testing Strategies and Treatment Decisions in the Era of Targeted Therapy

December 18th 2025

On October 6, 2025, a panel of medical oncologists specializing in advanced breast cancer participated in a virtual workshop to examine the optimization of testing strategies and treatment decisions for ESR1-mutated HR+/HER2- metastatic breast cancer.